doi: 10.1378/chest.62.5.534.
The use of expiratory forced flows for determining response to bronchodilator therapy
- PMID: 4563061
- DOI: 10.1378/chest.62.5.534
Item in Clipboard
The use of expiratory forced flows for determining response to bronchodilator therapy
Chest.
1972 Nov.
No abstract available
Similar articles
-
The one best test for evaluating the effects of bronchodilator therapy.Chest. 1977 Oct;72(4):512-6. doi: 10.1378/chest.72.4.512. Chest. 1977. PMID: 908220 No abstract available.
-
Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease.Clin Pharmacol Ther. 1974 Sep;16(3):499-506. doi: 10.1002/cpt1974163part1499. Clin Pharmacol Ther. 1974. PMID: 4606289 Clinical Trial. No abstract available.
-
Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.Thorax. 1973 Nov;28(6):716-20. doi: 10.1136/thx.28.6.716. Thorax. 1973. PMID: 4787983 Free PMC article.
-
Nebulized bronchodilators in obstructive lung disease. II.Ann Allergy. 1972 Feb;30(2):69-85. Ann Allergy. 1972. PMID: 4551435 Review. No abstract available.
-
Effect of intermittent positive pressure breathing on steady state chronic obstructive pulmonary disease.Am Rev Respir Dis. 1974 Dec;110(6 Pt 2):178-82. doi: 10.1164/arrd.1974.110.6P2.178. Am Rev Respir Dis. 1974. PMID: 4613225 Review. No abstract available.
Cited by
-
Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.Eur J Clin Pharmacol. 1978 May 31;13(3):171-7. doi: 10.1007/BF00609979. Eur J Clin Pharmacol. 1978. PMID: 352703 Clinical Trial. No abstract available.
-
Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography-Defined Underlying Pathology.Tuberc Respir Dis (Seoul). 2022 Oct;85(4):302-312. doi: 10.4046/trd.2022.0029. Epub 2022 Jul 13. Tuberc Respir Dis (Seoul). 2022. PMID: 35822317 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
